← 返回

敲除 Satb1 重编程耗竭 CD8(+) T 细胞亚群的分化轨迹以增强抗肿瘤免疫

英文原题:Ablating Satb1 reprograms the differentiation trajectory of exhausted CD8(+) T subsets to enhance antitumor immunity.

查看英文原题

Ablating Satb1 reprograms the differentiation trajectory of exhausted CD8(+) T subsets to enhance antitumor immunity.

PubMed 2026/06/22(内容时间) Front Immunol Q1 · IF 7(JCR 2025)

分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。

研究概要

我们的结果确定了 SATB1 是耗竭 CD8+ T 细胞亚群分化的关键调节因子,并提示将其作为靶点是一种有前景的策略,可扩增 Tex-int 群体以增强癌症免疫治疗。

研究思路结论见上方概要

在慢性感染或肿瘤中,持续的抗原暴露驱动CD8+ T细胞耗竭,这是一种异质性状态,涵盖从干细胞样祖细胞(Tpex)到过渡性效应样(Tex-int)细胞再到终末耗竭(Tex-term)亚群的分化连续体。在这些T细胞亚群中,Tex-int细胞是负责直接杀伤肿瘤细胞的主要群体。然而,调控Tpex向Tex-int转变的内在机制仍未完全明确。

在本研究中,我们探讨了特殊AT富集序列结合蛋白1(SATB1)在Tex-int细胞从其前体细胞分化过程中的作用。我们观察到在肿瘤中Tpex向Tex-int分化过程中SATB1下调。值得注意的是,在T细胞中基因敲除Satb1显著扩增了肿瘤浸润CD8+ T细胞(CD8+ TILs)的群体。

敲除 Satb1 不仅促进肿瘤微环境中 Tpex 细胞向 Tex-int 细胞分化,还通过从肿瘤特异性记忆 CD8+ T 细胞(T TSM)扩增 Tpex 池并驱动 Tpex1 向 Tpex2 转变,重塑肿瘤引流淋巴结(TdLNs)中的 T 细胞分化,从而增加肿瘤中 Tex-int 的生成。尽管 Satb1 缺陷小鼠的早期 Tex-int 细胞相对于对照组表现出短暂的功能受损,但这种差异在晚期肿瘤中不再明显,此时持续的 Tex-int 积累与显著抑制的肿瘤生长和延长的生存期相关。

展开英文摘要原文

In this study, we explore the role of special AT-rich sequence-binding protein 1 (SATB1) in the differentiation of Tex-int cells from their precursors. We observed downregulation of SATB1 during Tpex-to-Tex-int differentiation in tumors. Notably, the genetic ablation of Satb1 in T cells markedly expanded the population of tumor-infiltrating CD8 + T cells (CD8 + TILs).

Ablating Satb1 not only promoted the differentiation of Tex-int cells from Tpex cells within the tumor microenvironment but also remodeled T cell differentiation in tumor-draining lymph nodes (TdLNs) by expanding the Tpex pool from tumor-specific memory CD8 + T cells (T TSM ) and driving the Tpex1 to Tpex2 transition, thereby augmenting Tex-int production in tumors. Although early-stage Tex-int cells in Satb1 -deficient mice displayed transient functional impairment relative to controls, this difference was no longer evident in late-stage tumors, where sustained Tex-int accumulation correlated with significantly suppressed tumor growth and prolonged survival. DISCUSSION: Our results identify SATB1 as a pivotal regulator of exhausted CD8 + T cell subset differentiation and suggest its targeting as a promising strategy to expand the Tex-int population for enhanced cancer immunotherapy.

论文信息

作者
Wu L、Jiang H、Gao J、Ji X、Chen Y、Ma Z、Li X、Wang J
单位
The First Affiliated Hospital of Soochow University and The Second Affiliated Hospital of Soochow University and The Fourth Affiliated Hospital of Soochow University and School of Basic Medical Sciences, Suzhou Medical College, Soochow University, Suzhou, China.China
期刊
Frontiers in immunology2026
原文标识
PubMed 42440698 · DOI 10.3389/fimmu.2026.1744549